David A. Lipkin focuses his practice on mergers and acquisitions (M&A) and related securities law matters for companies in the technology and life sciences sectors. He represents both public and private acquirers and target companies, as well as special committees, in large, complex and sophisticated M&A transactions, including tender offers, negotiated mergers and other acquisition structures involving both strategic investors and private equity firms.
Read full biography: https://www.mwe.com/people/lipkin-david/